[HTML][HTML] A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, M H-Velkei, CZ Oláh… - Geroscience, 2022 - Springer
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

[PDF][PDF] A naturally hypersensitive porcine model may help understand the mechanism of COVID‑19 mRNA vaccine‑induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, MH‑Velkei, CZ Oláh… - 2022 - d-nb.info
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement …

L Dézsi, T Mészáros, G Kozma, H Mária… - …, 2022 - pubmed.ncbi.nlm.nih.gov
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

[PDF][PDF] A naturally hypersensitive porcine model may help understand the mechanism of COVID‑19 mRNA vaccine‑induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, MH‑Velkei, CZ Oláh… - 2022 - researchgate.net
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

[PDF][PDF] A naturally hypersensitive porcine model may help understand the mechanism of COVID‑19 mRNA vaccine‑induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, MH‑Velkei, CZ Oláh… - 2022 - scienceopen.com
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement …

L Dézsi, T Mészáros, G Kozma, M H-Velkei, CZ Oláh… - Geroscience, 2022 - europepmc.org
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement …

L Dézsi, T Mészáros, G Kozma, CZ Oláh… - …, 2022 - search.ebscohost.com
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

[PDF][PDF] A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, C Oláh, M Szabó… - 2022 - dea.lib.unideb.hu
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …

A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement …

L Dézsi, T Mészáros, G Kozma, M H-Velkei, CZ Oláh… - GeroScience, 2022 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> A tiny fraction of people immunized with lipid
nanoparticle (LNP)-enclosed mRNA (LNP-mRNA) vaccines develop allergic symptoms …

[HTML][HTML] A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions …

L Dézsi, T Mészáros, G Kozma, H Mária… - …, 2022 - pmc.ncbi.nlm.nih.gov
A tiny fraction of people immunized with lipid nanoparticle (LNP)-enclosed mRNA (LNP-
mRNA) vaccines develop allergic symptoms following their first or subsequent vaccinations …